Atlas Trials

A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome

Clinical trial NCT03899337 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03899337
Sponsor
University of Birmingham
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Richter Syndrome
Start date
2019-07-23
Primary completion
2028-06-30
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.